Robert Vollbracht
Neurology · Clearwater, FLNPI 1982653226
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,264 of the $29,794 with a category attached, or 84.8%. AbbVie accounts for 91.8% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $29,577 and has fallen 99.6% since, to $124 in 2021.
Across 190 payments — averaging $156.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$27K
- Teva Pharmaceuticals USA, Inc.$260
- Lilly USA, LLC$253
- Acadia Pharmaceuticals Inc$246
- Sunovion Pharmaceuticals Inc.$181
- Adamas Pharmaceuticals, Inc.$161
- plus $1K from 25 others
What the payments were for
- Consulting fees$3751%
- Speaking & faculty fees$25,26485%
- Travel & lodging$7823%
- Food & beverage$3,37411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $27,340 |
| Teva Pharmaceuticals USA, Inc. | 13 | $260 |
| Lilly USA, LLC | 14 | $253 |
| Acadia Pharmaceuticals Inc | 15 | $246 |
| Sunovion Pharmaceuticals Inc. | 12 | $181 |
| Adamas Pharmaceuticals, Inc. | 9 | $161 |
| Novartis | 6 | $137 |
| Amgen | 8 | $137 |
| Biohaven Pharmaceuticals, Inc. | 1 | $124 |
| Avanir Pharmaceuticals, Inc. | 7 | $97 |
| Bausch Health US, LLC | 5 | $91 |
| Lundbeck LLC | 4 | $88 |
| UCB, Inc. | 5 | $86 |
| Jazz Pharmaceuticals Inc. | 5 | $83 |
| Arbor Pharmaceuticals, Inc. | 4 | $79 |
| Eisai Inc. | 3 | $59 |
| Supernus Pharmaceuticals, Inc. | 4 | $49 |
| Neurocrine Biosciences, Inc. | 2 | $44 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| Upsher-smith Laboratories LLC | 2 | $31 |
| Merz North America, Inc. | 1 | $30 |
| Promius Pharma LLC | 2 | $26 |
| Zyla Life Sciences, Inc. | 2 | $24 |
| Acorda Therapeutics, Inc | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| GRT US Holding, Inc. | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Livanova USA, Inc. | 1 | $16 |
| CSL Behring | 1 | $16 |
| GE HealthCare | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$26,608
- AJOVY$125
- NURTEC ODT$124
How this compares
$29,794 in reported general payments places this provider in the 85th percentile of 1,434 neurology providers in Florida.
Other neurology in Clearwater
- Jean-Raphael SchneiderClearwater$219K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.